AMIE HELLMAN: Open Payments
NPI 1477852408 · ZEPHYRHILLS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,586 in 134 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $2,586
Food & beverage: $2,451Education: $134
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $563 |
| UCB, Inc. | 14 | $254 |
| Teva Pharmaceuticals USA, Inc. | 13 | $247 |
| Eisai Inc. | 8 | $211 |
| PFIZER INC. | 17 | $178 |
| SK Life Science, Inc. | 5 | $175 |
| Neurocrine BioSciences, Inc. | 11 | $152 |
| Novartis Pharmaceuticals Corporation | 3 | $109 |
| TG Therapeutics, Inc. | 5 | $102 |
| Neurelis, Inc. | 1 | $88 |
Products named: QULIPTA, Leqembi, UBRELVY, NURTEC ODT, AUSTEDO XR, INGREZZA, Nayzilam, KESIMPTA.
Industry payments across FL — which companies pay providers there.
